Abstract
COVID-19 became the most challenging health, economic, and social problem of the entire world from the beginning of 2020. Despite the first insight about COVID-19 in children, more critical involvement of children was observed. However, World Health Organization has not approved any preventive drug or curative antibiotic for COVID-19 infection [1], and reports on COVID-19 pharmacological treatment in children are limited. Pediatricians have concerns about the effect of common pharmacological treatments of COVID-19 in pediatric cases. Safety and efficacy of pharmacological treatments in hospitalized children are controversial.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Clinical Images and Medical Case Reports
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
